- Home
- SPRY vs CERT Comparison
SPRY vs CERT Comparison
Compare SPRY & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- CERT
- Stock Information
- Founded
- SPRY 2015
- CERT 2008
- Country
- SPRY United States
- CERT United States
- Employees
- SPRY N/A
- CERT N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SPRY Health Care
- CERT Technology
- Exchange
- SPRY Nasdaq
- CERT Nasdaq
- Market Cap
- SPRY 1.8B
- CERT 1.7B
- IPO Year
- SPRY N/A
- CERT 2020
- Fundamental
- Price
- SPRY $13.51
- CERT $10.85
- Analyst Decision
- SPRY Strong Buy
- CERT Buy
- Analyst Count
- SPRY 4
- CERT 7
- Target Price
- SPRY $28.75
- CERT $15.00
- AVG Volume (30 Days)
- SPRY 1.8M
- CERT 1.4M
- Earning Date
- SPRY 08-13-2025
- CERT 08-06-2025
- Dividend Yield
- SPRY N/A
- CERT N/A
- EPS Growth
- SPRY N/A
- CERT N/A
- EPS
- SPRY N/A
- CERT 0.05
- Revenue
- SPRY $112,339,000.00
- CERT $405,755,000.00
- Revenue This Year
- SPRY N/A
- CERT $12.38
- Revenue Next Year
- SPRY $170.64
- CERT $7.49
- P/E Ratio
- SPRY N/A
- CERT $231.19
- Revenue Growth
- SPRY 22367.80
- CERT 11.61
- 52 Week Low
- SPRY $10.00
- CERT $8.64
- 52 Week High
- SPRY $18.90
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- SPRY 31.35
- CERT 56.95
- Support Level
- SPRY $13.51
- CERT $10.59
- Resistance Level
- SPRY $15.09
- CERT $11.55
- Average True Range (ATR)
- SPRY 1.00
- CERT 0.49
- MACD
- SPRY -0.32
- CERT 0.10
- Stochastic Oscillator
- SPRY 2.17
- CERT 89.98
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.